104 related articles for article (PubMed ID: 38733826)
1. A novel Senescence-Based prognostic model unveils tumor interactions and drug resistance in colorectal cancer.
Yue Y; She X; Ding W; Chen S; Xiao Q; Pan B; Zhou L; Yin Y; Li Y; Wang S; Xu M
Int Immunopharmacol; 2024 Jun; 134():112197. PubMed ID: 38733826
[TBL] [Abstract][Full Text] [Related]
2. Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis.
Shen CJ; Chang KY; Lin BW; Lin WT; Su CM; Tsai JP; Liao YH; Hung LY; Chang WC; Chen BK
Theranostics; 2020; 10(16):7083-7099. PubMed ID: 32641980
[No Abstract] [Full Text] [Related]
3. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
4. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
Yu S; Chen M; Xu L; Mao E; Sun S
Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
[TBL] [Abstract][Full Text] [Related]
5. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer.
Lin XL; Yang L; Fu SW; Lin WF; Gao YJ; Chen HY; Ge ZZ
Oncotarget; 2017 May; 8(20):33586-33600. PubMed ID: 28422720
[TBL] [Abstract][Full Text] [Related]
7. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
[TBL] [Abstract][Full Text] [Related]
8. A novel prognostic signatures based on metastasis- and immune-related gene pairs for colorectal cancer.
Pan B; Yue Y; Ding W; Sun L; Xu M; Wang S
Front Immunol; 2023; 14():1161382. PubMed ID: 37180113
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
Front Immunol; 2022; 13():984480. PubMed ID: 36389763
[TBL] [Abstract][Full Text] [Related]
10. A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer.
Xu C; Li F; Liu Z; Yan C; Xiao J
Front Immunol; 2022; 13():1019764. PubMed ID: 36275644
[TBL] [Abstract][Full Text] [Related]
11. A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis.
Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; Zong Z; Zeng B; Li Y; Zhou T
J Gastrointest Oncol; 2022 Aug; 13(4):1842-1863. PubMed ID: 36092325
[TBL] [Abstract][Full Text] [Related]
12. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
Liu J; Yu F; Liu Z; Wang X; Li J
Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
[No Abstract] [Full Text] [Related]
13. Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA‑485‑5p/CKS1B axis.
Wang X; Tao G; Huang D; Liang S; Zheng D
Oncol Rep; 2020 Nov; 44(5):2009-2020. PubMed ID: 32901890
[TBL] [Abstract][Full Text] [Related]
14. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
[TBL] [Abstract][Full Text] [Related]
15. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation.
Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S
Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
[TBL] [Abstract][Full Text] [Related]
17. Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer.
Zhang X; Huang Y; Li Q; Zhong Y; Zhang Y; Hu J; Liu R; Luo X
Front Immunol; 2023; 14():1265911. PubMed ID: 37828981
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Macrophages Promote Oxaliplatin Resistance
Lan H; Liu Y; Liu J; Wang X; Guan Z; Du J; Jin K
Mol Pharm; 2021 Mar; 18(3):1026-1037. PubMed ID: 33555197
[TBL] [Abstract][Full Text] [Related]
20. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
